医疗服务提供者在人乳头瘤病毒疫苗接种计划中的作用——一份会议报告。
The role of healthcare providers in HPV vaccination programs - A meeting report.
作者信息
Vorsters Alex, Bonanni Paolo, Maltezou Helena C, Yarwood Joanne, Brewer Noel T, Bosch F Xavier, Hanley Sharon, Cameron Ross, Franco Eduardo L, Arbyn Marc, Muñoz Nubia, Kojouharova Mira, Pattyn Jade, Baay Marc, Karafillakis Emilie, Van Damme Pierre
机构信息
Centre for the Evaluation of Vaccination, University of Antwerp, Belgium.
University of Florence, Health Sciences, Florence, Italy.
出版信息
Papillomavirus Res. 2019 Dec;8:100183. doi: 10.1016/j.pvr.2019.100183. Epub 2019 Aug 30.
Abstract
The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available.
摘要
人类乳头瘤病毒（HPV）防控委员会于2018年5月在罗马尼亚布加勒斯特召开会议，讨论医疗服务提供者（HCPs）在预防项目中的作用，重点是HPV疫苗接种和宫颈癌筛查。国际和当地专家讨论了HCPs在提高HPV疫苗接种率和筛查率方面可发挥的作用。专家建议：1）提高HCPs的疫苗接种率标准；2）培训医疗服务提供者以提出有效的建议；3）提供使用当地语言且符合文化背景的资料；4）集中并协调教育和信息资料，引导HCPs和普通公众获取最佳可用资料。
相似文献
1
The role of healthcare providers in HPV vaccination programs - A meeting report.
Papillomavirus Res. 2019 Dec;8:100183. doi: 10.1016/j.pvr.2019.100183. Epub 2019 Aug 30.
2
Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents.
Vaccine. 2017 Feb 1;35(5):802-807. doi: 10.1016/j.vaccine.2016.12.045. Epub 2017 Jan 4.
3
Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015.
Prev Chronic Dis. 2017 Sep 28;14:E85. doi: 10.5888/pcd14.160610.
4
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
5
Knowledge, attitude & practice on human papillomavirus vaccination: A cross-sectional study among healthcare providers.
Indian J Med Res. 2016 Nov;144(5):741-749. doi: 10.4103/ijmr.IJMR_1106_14.
6
Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Int J Infect Dis. 2007 Nov;11 Suppl 2:S26-8. doi: 10.1016/S1201-9712(07)60018-6.
7
Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers: A qualitative study based on multi-theory model.
PLoS One. 2020 Oct 16;15(10):e0240657. doi: 10.1371/journal.pone.0240657. eCollection 2020.
8
Awareness and Knowledge About HPV and HPV Vaccine Among Romanian Women.
J Cancer Educ. 2018 Feb;33(1):154-159. doi: 10.1007/s13187-016-1130-2.
9
A model of health care provider decision making about HPV vaccination in adolescent males.
Vaccine. 2015 Aug 7;33(33):4081-6. doi: 10.1016/j.vaccine.2015.06.085. Epub 2015 Jul 2.
10
Up to date: comprehensive knowledge of human papillomavirus.
Expert Rev Vaccines. 2013 Apr;12(4):353-5. doi: 10.1586/erv.13.8.
引用本文的文献
1
Accelerating HPV-related cancer elimination - a meeting report.
BMC Proc. 2025 Aug 29;19(Suppl 19):22. doi: 10.1186/s12919-025-00337-1.
2
Exploring Vulnerable, Ethnic Minority, and Low Socioeconomic Children's Knowledge, Beliefs, and Attitudes Regarding HPV Vaccination in Romania.
Healthcare (Basel). 2025 Aug 15;13(16):2010. doi: 10.3390/healthcare13162010.
3
Parental acceptance of human papillomavirus vaccine for female adolescents in Abia State, southeastern Nigeria: a pre-implementation study.
Pan Afr Med J. 2025 Jun 13;51:44. doi: 10.11604/pamj.2025.51.44.43317. eCollection 2025.
4
Vaccine Knowledge, Attitude, and Hesitancy Among Healthcare Professionals in the Kingdom of Bahrain: A Cross-Sectional Survey.
Cureus. 2025 Apr 18;17(4):e82519. doi: 10.7759/cureus.82519. eCollection 2025 Apr.
5
The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review.
BMC Public Health. 2025 Apr 3;25(1):1254. doi: 10.1186/s12889-025-22343-w.
6
Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2402122. doi: 10.1080/21645515.2024.2402122. Epub 2024 Oct 14.
7
Healthcare Professionals' Perspectives on HPV Recommendations: Themes of Interest to Different Population Groups and Strategies for Approaching Them.
Vaccines (Basel). 2024 Jul 6;12(7):748. doi: 10.3390/vaccines12070748.
8
Exploring the Impact of Knowledge about the Human Papillomavirus and Its Vaccine on Perceived Benefits and Barriers to Human Papillomavirus Vaccination among Adults in the Western Region of Saudi Arabia.
Healthcare (Basel). 2024 Jul 20;12(14):1451. doi: 10.3390/healthcare12141451.
9
DNA methylation as a triage tool for cervical cancer screening - A meeting report.
Prev Med Rep. 2024 Mar 6;41:102678. doi: 10.1016/j.pmedr.2024.102678. eCollection 2024 May.
10
A systematic review of measures of healthcare workers' vaccine confidence.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2322796. doi: 10.1080/21645515.2024.2322796. Epub 2024 Mar 20.
本文引用的文献
1
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.
BMJ. 2019 Apr 3;365:l1161. doi: 10.1136/bmj.l1161.
2
Populist politics and vaccine hesitancy in Western Europe: an analysis of national-level data.
Eur J Public Health. 2019 Jun 1;29(3):512-516. doi: 10.1093/eurpub/ckz004.
3
Questions and Concerns About HPV Vaccine: A Communication Experiment.
Pediatrics. 2019 Feb;143(2). doi: 10.1542/peds.2018-1872. Epub 2019 Jan 22.
4
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
5
Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illness.
Vaccine. 2018 Jan 4;36(2):299-305. doi: 10.1016/j.vaccine.2017.11.017. Epub 2017 Nov 29.
6
Overcoming barriers in HPV vaccination and screening programs.
Papillomavirus Res. 2017 Dec;4:45-53. doi: 10.1016/j.pvr.2017.07.001. Epub 2017 Jul 20.
7
Vaccination in pregnancy: Attitudes of nurses, midwives and health visitors in England.
Hum Vaccin Immunother. 2018 Jan 2;14(1):179-188. doi: 10.1080/21645515.2017.1382789. Epub 2017 Nov 27.
8
Pediatrician-Parent Conversations About Human Papillomavirus Vaccination: An Analysis of Audio Recordings.
J Adolesc Health. 2017 Aug;61(2):246-251. doi: 10.1016/j.jadohealth.2017.02.006. Epub 2017 Apr 25.
9
Changing attitudes to childhood immunisation in English parents.
Vaccine. 2017 May 19;35(22):2979-2985. doi: 10.1016/j.vaccine.2017.03.089. Epub 2017 Apr 23.
10
Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial.
Pediatrics. 2017 Jan;139(1). doi: 10.1542/peds.2016-1764. Epub 2016 Dec 5.
Zotero 插件